The percentage of CD8+ HLA-DR+ T cells was not statistically different when R patients were grouped according to cancer stage or menopause status, while this percentage was increased in DN patients when they were grouped by expression of hormone receptors (Figure 1E–G). This evidence concerns the gene NR4A1 and cancer.